WallStreetZenWallStreetZen

How to Buy Dexcom Stock

Dexcom Inc

DexCom, Inc. , a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

Dexcom stock last closed at $118.89, up 0.81% from the previous day, and has increased 0.83% in one year. It has overperformed other stocks in the Medical Devices industry by 0.19 percentage points. Dexcom stock is currently +59.05% from its 52-week low of $74.75, and -14.8% from its 52-week high of $139.55.

At the moment, there are 386.37M DXCM shares outstanding. The market capitalization of DXCM is $45.94B. In the past 24 hours, 2.39M DXCM shares were traded.

How to Buy Dexcom Stock

Wondering how to invest in Dexcom stock? Here's how.
  1. Choose where to buy Dexcom stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Dexcom stock.
  2. Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
  3. Put funds into your brokerage account: Choose your payment method and add your info.
  4. Research Dexcom stock: The Dexcom ticker symbol is DXCM. Is Dexcom stock a good investment? Should you buy shares of DXCM? How do DXCM's underlying business fundamentals look? Do top analysts think Dexcom is a good buy? Why has DXCM's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if DXCM is a good stock to buy).
  5. Execute your DXCM purchase: Decide if you will purchase DXCM shares at the current market price or use a limit order to buy DXCM shares at a particular price.
  6. Keep an eye on your DXCM position: Create a watchlist to monitor your investment in Dexcom stock.

Step 1: Choose where to buy Dexcom stock

You will need an online brokerage account to access the NASDAQ market and buy DXCM stock.

A brokerage account enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

We believe that eToro is the best brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global markets: From Technology to Industrials, New York to London — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by creating an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've selected your brokerage, it's time to fill out some personal information so you are able to invest in DXCM stock today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to open your new trading account.
  1. Submit your application by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your brokerage account

Now that you have created your account on stock apps to use, your next step is to transfer the money for your investment:

Check out the video below to see the process of transferring funds into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Dexcom stock

Once you have selected the best place to buy Dexcom stock, it's crucial to evaluate their stock prior to buying, so you truly wrap your head around the risk as well as the upside.

Dexcom quick stats

DXCM Price
$118.89
1w %
2.92%
1y %
0.83%
5y %
291.7%
P/E
121.32x
P/B
20.25x
P/S
13.51x
PEG
5.89x
Revenue
$3.40B
Earnings
$377.00M
Fore. Rev. Growth
13.5%
Fore. Earn. Growth
20.58%
Market Cap
$45.94B
Next Earnings
Feb 7, 2024
Next Dividend
N/A

Dexcom Due Diligence Checks

WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.

You can see all of the due diligence checks on DXCM's stock page.

Is DXCM stock overvalued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge DXCM's intrinsic value.

Using relative valuations metrics:

  • DXCM could be overvalued based on its P/E ratio of 121.32x, relative to Medical Devices industry P/E ratio of 34.08x
  • DXCM may be overvalued based on its P/B ratio of 20.25x, relative to Medical Devices industry P/B ratio of 3.55x
  • DXCM may be overvalued based on its PEG ratio of 5.89x

You can do additional valuation analysis on DXCM's stock here.

DXCM Financial Health

Passed Financial Due Diligence Checks:

  • DXCM profit margin has gone up from 8.7% to 11.1% in the past year.
  • DXCM earnings of $578.20M is not enough to cover its interest payments.
  • There are more short-term assets than short-term liabilities on the DXCM balance sheet.
  • DXCM's operating cash flow of $747.40M allows it to safely service it's debt of $2.66B.
  • There are more short-term assets than long-term liabilities on the DXCM balance sheet.

Failed Financial Due Diligence Checks:

  • Total DXCM debt is higher than 5 years ago, relative to shareholder equity.
  • DXCM has a relatively high debt to equity ratio of 1.91.

Is DXCM stock a Buy, Hold, or Sell, according to analysts?

Out of 12 Wall Street analysts who give recommendations on DXCM, the consensus analyst rating on Dexcom is a Strong Buy

Please note that analyst forecasts are not recommendations, nor are they investment advice.

Latest DXCM Analyst Upgrades/Downgrades

Danielle Antalffy, a bottom 3% analyst from UBS maintains DXCM with a strong buy rating and lowers their DXCM price target from $175.00 to $138.00, on Sep 6, 2023.

Jeff Johnson, a top 14% analyst from Baird maintains DXCM with a buy rating and lowers their DXCM price target from $153.00 to $130.00, on Aug 21, 2023.

Matt Miksic, a bottom 5% analyst from Barclays maintains DXCM with a hold rating and raises their DXCM price target from $115.00 to $138.00, on Jul 31, 2023.

Matthew O'Brien, a bottom 5% analyst from Piper Sandler maintains DXCM with a strong buy rating and raises their DXCM price target from $150.00 to $160.00, on Jul 28, 2023.

Kyle Rose, a top 10% analyst from Canaccord Genuity maintains DXCM with a strong buy rating and raises their DXCM price target from $135.00 to $150.00, on Jul 28, 2023.

Canaccord Genuity's Kyle Rose raised their price target on Dexcom Inc (NASDAQ: DXCM) by 11.11% from $135.00 to $150.00 on 2023/07/28. The analyst maintained their Strong Buy rating on the stock.

The analyst said they raised their PT to reflect the "impressive" Q2 2023 results DexCom delivered on 2023/07/27.

The company posted a beat on revenue and earnings, together with another quarterly record for new patient adds, Rose reported.

In addition, management raised its FY 2023 revenue guidance to account for the company's "solid" 1H performance, the analyst said, "particularly the robust onboarding of basal-only T2 patients."

Footnotes

For Q2 2023, DexCom reported:

  • EPS of $0.34, which beat the Zacks Consensus Estimate of $0.22 and, by 100%, Q2 2022’s $0.17.
  • Revenue of $871.3M, which beat the Zacks Consensus Estimate of $836.98M and, by 25.2%, Q2 2022’s $696.2M.
  • Gross profit margin of 63.5%.
  • Operating income of $128.1M.
  • Adjusted EBITDA of 232.6M.

Management guided for FY 2023:

  • Revenue of $3.5B to 3.55B.
  • Gross profit margin of 63%.
  • Operating margin of 17%.
  • Adjusted EBITDA margin of 26.5%.

CEO Kevin Sayer commented, “In Q2, we advanced several key strategic initiatives and shared our latest vision for the future of Dexcom at our 2023 Investor Day.

 “Given our strong start to the year and rapidly growing market opportunity, we are pleased to raise our 2023 revenue and margin guidance.”

You can dig deeper into what analysts are forecasting on the Dexcom stock forecast page.

DXCM Momentum

SMA10
115.97
SMA20
109.32
SMA50
95.98
SMA100
102.6
SMA200
111.39
MACD
6.57
MACD Signal
6.2
MACD Histogram
0.37
RSI
74.86
Stochastic %K
93.58
Stochastic %D
94.11
StochRSI %K
75.81
StochRSI %D
81

How is DXCM performing as a company?

Last year, DXCM earnings were $377.00M. During the past 5 year, DXCM's earnings have increased by 52.2% per year. This was faster than the Medical Devices industry average of 21.12%.

Last year, DXCM revenue was $3.40B. In the past 5 year, DXCM's revenue has grown by 30.05% per year. This was faster than the Medical Devices industry average of 12.72%.

You can analyze DXCM's earnings and revenue performance here.

What are DXCM executives and large shareholders up to?

Over the last year, executives and large shareholders at DXCM have sold more shares than they have bought.

Michael Jon Brown, EVP Chief Legal Officer of DXCM, was the latest DXCM insider to sell. They sold $135,043.74 worth of DXCM stock on Dec 1, 2023.

Research more about who owns DXCM shares here.

Does DXCM provide a stable income stream?

No, Dexcom doesn't provide an income stream by paying out dividends.

Get analysis from other investors

One of the reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Execute your DXCM purchase

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at an exact dollar amount, place a limit order.

Hit the Open Trade button and eToro will execute your order.

If you want more info about investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep an eye on your DXCM position

Now that you own some DXCM shares, you'll want to stay up-to-date on your new investment.

Make a watchlist to get notified of important updates regarding your DXCM stock.

DXCM Feed

How to Buy Stock in Dexcom

To reiterate, here are the 6 steps for buying Dexcom stock:

  1. Choose where to buy Dexcom stock
  2. Create a brokerage account
  3. Put funds into your brokerage account
  4. Research Dexcom stock
  5. Execute your DXCM purchase
  6. Keep an eye on your DXCM position

If you need a brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to monitor your investment in Dexcom, create a watchlist on WallStreetZen today.

NASDAQ: DXCM
$118.89+0.95 (+0.81%)
Updated Dec 7, 2023
Open eToro Account
NASDAQ: DXCM
$118.89+0.95 (+0.81%)
Updated Dec 7, 2023
Open eToro Account

FAQ

How much does it cost to buy one Dexcom share?

As of Dec 7, 2023, it costs $118.89 to buy one share of Dexcom stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.084 shares of DXCM.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Dexcom stock?

According to 12 Wall Street analysts who monitor Dexcom, their consensus recommendation is to buy Dexcom stock.

What is the best way to buy Dexcom stock?

One way to place an order for Dexcom stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.